These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 35234441)

  • 1. Bioengineered Protein Nanocage by Small Heat Shock Proteins Delivering mTERT siRNA for Enhanced Colorectal Cancer Suppression.
    Wang H; Liu N; Yang F; Hu N; Wang M; Cui M; Bruns N; Guan X
    ACS Appl Bio Mater; 2022 Mar; 5(3):1330-1340. PubMed ID: 35234441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engineered Hsp Protein Nanocages for siRNA Delivery.
    Guan X; Chang Y; Sun J; Song J; Xie Y
    Macromol Biosci; 2018 May; 18(5):e1800013. PubMed ID: 29665276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Codelivery of GRP78 siRNA and docetaxel via RGD-PEG-DSPE/DOPA/CaP nanoparticles for the treatment of castration-resistant prostate cancer.
    Zhang X; He Z; Xiang L; Li L; Zhang H; Lin F; Cao H
    Drug Des Devel Ther; 2019; 13():1357-1372. PubMed ID: 31118572
    [No Abstract]   [Full Text] [Related]  

  • 4. RNAi-mediated gene knockdown and anti-angiogenic therapy of RCCs using a cyclic RGD-modified liposomal-siRNA system.
    Sakurai Y; Hatakeyama H; Sato Y; Hyodo M; Akita H; Ohga N; Hida K; Harashima H
    J Control Release; 2014 Jan; 173():110-8. PubMed ID: 24120854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor microenvironment targeting with dual stimuli-responsive nanoparticles based on small heat shock proteins for antitumor drug delivery.
    Shi K; Wang Y; Zhou X; Gui H; Xu N; Wu S; He C; Zhao Z
    Acta Biomater; 2020 Sep; 114():369-383. PubMed ID: 32688090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Virus-mimetic polymeric micelles for targeted siRNA delivery.
    Xiong XB; Uluda─č H; Lavasanifar A
    Biomaterials; 2010 Aug; 31(22):5886-93. PubMed ID: 20427082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RGD-based active targeting of novel polycation liposomes bearing siRNA for cancer treatment.
    Yonenaga N; Kenjo E; Asai T; Tsuruta A; Shimizu K; Dewa T; Nango M; Oku N
    J Control Release; 2012 Jun; 160(2):177-81. PubMed ID: 22019557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-targeted inhibition by a novel strategy - mimoretrovirus expressing siRNA targeting the Pokemon gene.
    Tian Z; Wang H; Jia Z; Shi J; Tang J; Mao L; Liu H; Deng Y; He Y; Ruan Z; Li J; Wu Y; Ni B
    Curr Cancer Drug Targets; 2010 Dec; 10(8):932-41. PubMed ID: 20879980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multifunctional PEI-entrapped gold nanoparticles enable efficient delivery of therapeutic siRNA into glioblastoma cells.
    Kong L; Qiu J; Sun W; Yang J; Shen M; Wang L; Shi X
    Biomater Sci; 2017 Jan; 5(2):258-266. PubMed ID: 27921110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene augmented nuclear-targeting sonodynamic therapy via Nrf2 pathway-based redox balance adjustment boosts peptide-based anti-PD-L1 therapy on colorectal cancer.
    Wan G; Chen X; Wang H; Hou S; Wang Q; Cheng Y; Chen Q; Lv Y; Chen H; Zhang Q
    J Nanobiotechnology; 2021 Oct; 19(1):347. PubMed ID: 34715867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lysosomal escaped protein nanocarriers for nuclear-targeted siRNA delivery.
    Cao X; Shang X; Guo Y; Zheng X; Li W; Wu D; Sun L; Mu S; Guo C
    Anal Bioanal Chem; 2021 May; 413(13):3493-3499. PubMed ID: 33770206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Silencing KLK12 expression via RGDfC-decorated selenium nanoparticles for the treatment of colorectal cancer in vitro and in vivo.
    Xia Y; Tang G; Guo M; Xu T; Chen H; Lin Z; Li Y; Chen Y; Zhu B; Liu H; Cao J
    Mater Sci Eng C Mater Biol Appl; 2020 May; 110():110594. PubMed ID: 32204058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Failure of active targeting by a cholesterol-anchored ligand and improvement by altering the lipid composition to prevent ligand desorption.
    Yamamoto S; Sakurai Y; Harashima H
    Int J Pharm; 2018 Jan; 536(1):42-49. PubMed ID: 29126905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequential treatment of drug-resistant tumors with RGD-modified liposomes containing siRNA or doxorubicin.
    Jiang J; Yang SJ; Wang JC; Yang LJ; Xu ZZ; Yang T; Liu XY; Zhang Q
    Eur J Pharm Biopharm; 2010 Oct; 76(2):170-8. PubMed ID: 20600887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delivery of therapeutic shRNA and siRNA by Tat fusion peptide targeting BCR-ABL fusion gene in Chronic Myeloid Leukemia cells.
    Arthanari Y; Pluen A; Rajendran R; Aojula H; Demonacos C
    J Control Release; 2010 Aug; 145(3):272-80. PubMed ID: 20403398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of an efficient transdermal delivery system of small interfering RNA using functional peptides, Tat and AT-1002.
    Uchida T; Kanazawa T; Takashima Y; Okada H
    Chem Pharm Bull (Tokyo); 2011; 59(2):196-201. PubMed ID: 21297299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-tumor effects in mice induced by survivin-targeted siRNA delivered through polysaccharide nanoparticles.
    Yang F; Huang W; Li Y; Liu S; Jin M; Wang Y; Jia L; Gao Z
    Biomaterials; 2013 Jul; 34(22):5689-99. PubMed ID: 23632321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic effects on atopic dermatitis by anti-RelA short interfering RNA combined with functional peptides Tat and AT1002.
    Uchida T; Kanazawa T; Kawai M; Takashima Y; Okada H
    J Pharmacol Exp Ther; 2011 Aug; 338(2):443-50. PubMed ID: 21531792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic Effect of Tangeretin and Atorvastatin for Colon Cancer Combination Therapy: Targeted Delivery of These Dual Drugs Using RGD Peptide Decorated Nanocarriers.
    Bao H; Zheng N; Li Z; Zhi Y
    Drug Des Devel Ther; 2020; 14():3057-3068. PubMed ID: 32801644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Self-assembled nanoparticles based on the c(RGDfk) peptide for the delivery of siRNA targeting the VEGFR2 gene for tumor therapy.
    Liu L; Liu X; Xu Q; Wu P; Zuo X; Zhang J; Deng H; Wu Z; Ji A
    Int J Nanomedicine; 2014; 9():3509-26. PubMed ID: 25114522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.